Amphastar Pharma (NASDAQ: AMPH) was on watch ahead of "60 Minutes" reports on Naloxone. The reports were titled A DOSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE